Recent observations in the UK Biobank showed that carriers of the TTR pathogenic variant p.V142I have reduced TTR levels, with low TTR levels associated with increased risks of heart failure, cardiovascular mortality, and all-cause mortality [9]. Here, TTR is linked to heart failure.